Tags: fda | menopause | drug | approve

FDA Approves Post-Menopause Drug

FDA Approves Post-Menopause Drug
(Getty Images)

Wednesday, 30 May 2018 09:50 AM

The U.S. Food and Drug Administration (FDA) approved TherapeuticsMD Inc's hormone therapy for a painful condition triggered by menopause, giving the women's healthcompany its first approved drug.

The treatment, Imvexxy, treats a symptom of vulvar and vaginal atrophy, a condition caused by the loss of female hormone estrogen after menopause.

The drug is delivered via a softgel capsule inserted into the vagina, distinguishing it from competing products including Allergan Plc's Estrace cream and NovoNordisk's Vagifem insert.

Safety warnings on Imvexxy's label flag risks of endometrial cancer, cardiovascular disorders, breast cancer, and probable dementia.

Last year, the FDA declined to approve the drug, citing a requirement for long-term safety data, but allowed the company to apply for approval again without conducting a new study.

© 2019 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Health-News
The U.S. Food and Drug Administration (FDA) approved TherapeuticsMD Inc's hormone therapy for a painful condition triggered by menopause.
fda, menopause, drug, approve
123
2018-50-30
Wednesday, 30 May 2018 09:50 AM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved